BMGL
BMGL
NASDAQ · Health Care

Basel Medical Group Ltd

$0.68
-1.25 (-64.56%)
Financial Highlights (FY 2026)
Revenue
98.21M
Net Income
-92,278,223
Gross Margin
—
Profit Margin
-94.0%
Rev Growth
+2.0%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 98.21M 96.26M 6.80M 6.40M
Gross Profit — — 2.64M 2.49M
Operating Income -87,195,245 -76,914,359 808.2K 856.0K
Net Income -92,278,223 -81,398,020 795.8K 756.4K
Gross Margin — — 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Rev Growth +2.0% +2.0% -8.5% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 17.35M 17.35M 4.33M 4.62M
Total Equity 18.57M 18.57M 8.88M 9.45M
D/E Ratio 0.93 0.93 0.49 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -76,946,736 -71,645,005 1.21M 1.15M
Free Cash Flow — — 635.1K 614.1K